New Capital US Future Leaders Fund EUR Ord AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 70.2 | 0.7 | -37.9 | 28.8 | 10.2 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | EUR 158.54 | |
Day Change | 2.16% | |
Morningstar Category™ | Other Equity | |
ISIN | IE00BF2SJC17 | |
Fund Size (Mil) 21/11/2024 | USD 117.30 | |
Share Class Size (Mil) 21/11/2024 | EUR 2.47 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 31/05/2024 | 1.71% |
Investment Objective: New Capital US Future Leaders Fund EUR Ord Acc |
The investment objective of this Sub-Fund is to achieve capital appreciation through investment in a portfolio of equity securities. In order to achieve its investment objective, the Sub-Fund will invest in equities issued by US companies listed or traded on Recognised Markets in the United States such as the NASDAQ, the New York Stock Exchange, the American Stock Exchange, the Chicago Mercantile Exchange and the Chicago Board of Trade. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Michael Clulow 08/08/2018 | ||
Joel Rubenstein 08/08/2018 | ||
Click here to see others | ||
Inception Date 10/05/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Russell Mid Cap Growth TR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for New Capital US Future Leaders Fund EUR Ord Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
The Trade Desk Inc Class A | Technology | 4.72 |
Alnylam Pharmaceuticals Inc | Healthcare | 4.36 |
Fair Isaac Corp | Technology | 4.26 |
Palantir Technologies Inc Ordina... | Technology | 4.26 |
Ares Management Corp Ordinary Sh... | Financial Services | 3.98 |
Increase Decrease New since last portfolio | ||
New Capital US Future Leaders Fund EUR Ord Acc |